Abstract The nature of the process by which free fatty acids, which are tightly bound to albumin, traverse the endothelium of cardiac capillaries to reach the cardiac muscle cells, so that they are extracted to a net extent of =40O%, needs clarification. Previous provided reassurance that the inferences arising from the modeling analysis were likely correct.
clarification. Previous studies have indicated that a membrane fatty acid-binding protein provides for carrier-mediated uptake of free fatty acids by isolated hepatocytes, cardiomyocytes, and jejunal mucosal cells. A monoclonal monospecific antibody was prepared against purified membrane fatty acidbinding protein from rat liver. Multiple-indicator dilution experiments were carried out in the isolated rat heart with labeled albumin, sucrose, and palmitate in the presence of control perfusate or perfusate containing either specific antibody or comparable nonspecific myeloma cell supernatant (each of the latter containing additional albumin, in identical concentrations). Analysis of the labeled-sucrose curves provided a permeability-surface area product for sucrose to which that for palmitate could be compared. In comparison with control supernatants, myeloma supernatant produced a minor inhibition of palmitate uptake, as a result of the increase in albumin concentration. The specific antibody, which contained identical albumin concentrations, produced a major inhibition of palmitate uptake, significantly greater than with the myeloma supernatant. The Key Words * capillary transfer of free fatty acids * membrane free fatty acid-binding protein * antibody inhibition of free fatty acid transfer * mediated transfer of free fatty acid F ree fatty acids are the principal fuel of the heart ' and, although highly protein bound,2 are normally extracted in vivo to the extent of 40% to 50% during a single transit time. 3 Multiple-indicator dilution studies of labeled-palmitate uptake by the canine heart in vivo,4 analyzed with a model including the barriers represented by capillary and sarcolemmal surfaces,S demonstrated that the principal barrier to tracer entry is at the level of the capillary. The analysis of the tracer data indicated that the larger proportion of the unextracted labeled palmitate emerging at the outflow was material that had never left the capillary lumen during its passage through the heart; it emerged with its vascular reference, labeled albumin. The analysis also indicated that a major consequence of the combination of the presence of the capillary and sarcolemmal barriers together with the process of intracellular sequestration of label within the cardiac muscle cells was an expectation that the intracellular consumption of free fatty acids would lead to a quite low intracellular concentration, on the order of 6% of the average capillary plasma concentration. Later measurements in rapidly frozen heart tissue documented tissue free fatty acid levels that were of the order predicted.6 This provided reassurance that the inferences arising from the modeling analysis were likely correct.
Labeled albumin in plasma is exchanged with that present in the cardiac interstitium at a rate several orders of magnitude slower than the rate at which free fatty acid enters the interstitium7; its exchange during a single passage through the heart is too small to be measurable. The passage of free fatty acid from plasma (where it is bound to albumin) to the interstitium therefore occurs in a fashion independent of the exchange of albumin.
Labeled sucrose, a prototypic extracellular space reference, permeates capillaries in a paracellular fashion,8 with the proportion exchanging across cardiac capillaries varying with the transit time.9 Its extraction across the coronary circulation in vivo is smaller than that concomitantly observed for labeled palmitate. 4 In view of the comparable molecular weights of palmitate and sucrose and the exceedingly small proportion of fatty acid in plasma that is not bound to albumin, one can infer that paracellular passage of this fraction is much too small to account for the observed in vivo extraction. Passage across endothelial cells therefore must constitute the major part of the process. The question that arises is whether some passive physicochemical dissolution/permeation mechanism is at work or whether the exchange is facilitated by a relatively large capacity transport mechanism present at both surfaces of the capillary endothelial cells.
The present study was designed to examine this question. Previous studies demonstrated that, in the rat, a membrane fatty acid-binding protein mediates cell entry of fatty acids into hepatocytes, intestinal mucosal cells, and isolated cardiomyocytes.10-14 With the observation that a membrane protein mediates uptake of free fatty acids by heart muscle cells,'1314 the step remaining to be elucidated is that responsible for the transfer of free fatty acids from plasma to interstitium. To investigate this, we characterized, in the plasma-perfused isolated rat heart, the effect of a monospecific monoclonal antibody to the free fatty acid transport protein found in rat hepatocytes15 on the extraction of a representative long-chain fatty acid, [3H]palmitate, with the multiple-indicator dilution approach. If a mediating membrane protein is present in cardiac capillary endothelial cells, with an antibody recognition site similar to that for the hepatocytic protein, inhibition of the uptake process will be expected.
Materials and Methods Experimental Preparation
Rats of the Sprague-Dawley strain weighing 250 to 350 g were injected intraperitoneally with heparin (2.5 mg) 30 minutes before they were killed. The rats were anesthetized with pentobarbital (25 mg per rat), and the abdominal cavity was opened by making a transverse incision with scissors. The diaphragm was transected, and the rib cage was opened. The heart was cut free, with a short cuff of aorta, and dropped into a beaker containing saline chilled in ice water. Contractions stopped within a few seconds. When the heart had cooled for 15 to 20 seconds, the aorta was slipped -3 mm onto a grooved perfusion cannula, and this was secured in place. Retrograde perfusion down the aorta was begun from a reservoir 120 cm above the heart, guarding against bubbles.' The hearts were kept in a temperature-controlled compartment at 37°C and were perfused with Krebs-Henseleit solution containing 5.55 mmol/L glucose, 0.66 ,umol/L albumin, and 3.33 ,umol/L palmitate that was saturated with a mixture of 95% 02/5% CO2 and adjusted to a pH of 7.4. With rewarming, the heart began to beat vigorously once again.
The free fatty acid and albumin concentrations selected for the present set of experiments are arbitrary. In the absence of albumin, 95% of tracer palmitate is extracted by the isolated rabbit heart.16 In the presence of albumin, the extraction will be expected to be decreased. Normal albumin concentrations are on the order of 0.6 mmol/L, and fasting free fatty acid concentrations are on the order of 0.3 mmol/L. In the context of the present experiments, albumin also has another effect at the capillary level. In its absence and in the absence particularly of orosomucoid, capillary permeability is found to increase. Only low concentrations of the proteins are needed to prevent the increase from occurring,17'8 and the time for elution of orosomucoid from microvascular endothelial cells is >30 minutes. 19 Since the focus of the present experiments was the uptake of palmitate rather than the effect of albumin on this uptake, we selected a low albumin concentration and, with this, a high ratio of palmitate to albumin. We included in the perfusion a quite low concentration of albumin (0.66 gmol/L) and a palmitate concentration (3.33 gmol/L), which allows substantial cumulative extraction in the control experiments. The amount of perfusate prepared was limited; in consequence, experiments were necessarily completed within 20 minutes of beginning perfusion.
Experimental Design
The multiple-indicator dilution approach was used to examine the uptake of free fatty acids by a set of isolated perfused rat hearts. A 0.1-mL bolus containing 1 
Analysis of Samples
Ten microliters of each sample and of standards prepared from the injection mixture were diluted in 1 mL of normal saline, pipetted into a test tube, and then analyzed in a gamma ray spectrometer for ['lI]albumin. The protein was then precipitated with 0.2 mL of a 25% solution of trichloroacetic acid, and 0.2 mL of this supernatant was pipetted into Aquasol (New England Nuclear) scintillation cocktail and analyzed for 14C activity, with crossover corrections for any 3H and remaining 'lI activity. An aliquot of 0.05 mL of samples and standards was extracted by the method of Dole and Meinertz. 22 The heptane upper phase (0.2 mL) containing the free fatty acids was then pipetted into scintillation cocktail and assayed for 3H activity. The activity for each isotopic species in each venous sample was divided by the total of that activity injected and plotted against time after injection to give a normalized coronary sinus outflow fraction per milliliter versus time curve for each tracer. Curves were extended beyond the time of collection by the extrapolation of a semilogarithmic representation of the data. For identically recovered species, the area under each extrapolated normalized outflow curve is then expected to be the same. semilogarithmic format. In Fig 1, It is important to determine whether these perfused hearts had become edematous and whether the permeability of the capillaries increased during these experiments. To examine this, the relation between the labeled albumin and sucrose curves was used in two ways to provide information concerning these hearts. In the first kind of analysis, the interstitial space available to sucrose was estimated as the product of perfusate flow and the difference in the mean transit times of labeled sucrose and albumin. Values are listed in the Table. They are comparable in control and supernatant-containing infusions. The interstitial space sizes are close to values obtained in the in situ canine heart,23 presumably since the experiments were carried out soon after perfusion was started, before substantial swelling as a result of the low albumin infusion used as a perfusate. In the second kind of analysis, estimates of the permeability-surface area product for labeled sucrose as well as its interstitial space were derived from the relation between the two curves. The approach used was that previously developed by Rose The relation between the labeled albumin and palmitate curves provides the information needed to account for what is happening to palmitate. The average data for the whole set can be examined in a fashion that does not require modeling, by comparing the areas under the extrapolated labeled palmitate and labeled albumin curves (see the Table) . In the series using the K15/6 supernatant-containing infusions, the average of the ratio of the cumulative outflow of labeled palmitate with respect to that for labeled albumin was 0.62 in the control situation and 0.94 with the infusion of the specific antibody (tracer cumulative extraction therefore dropped from an average of 0.38 to 0.06); the change was highly significant (paired t test; the null hypothesis was rejected at the P<.01 level). In the series using the NS-1 supernatant-containing infusions, the mean area ratio increased from 0.66 to 0.80, and the labeled palmitate cumulative extractions decreased correspondingly from 0.34 to 0.20; the change was again highly significant (paired t test; the null hypothesis was rejected at the P<.01 level). The use of either supernatant-containing infusion resulted in a highly significant change in cumulative palmitate extraction, but the change with either of the two was of a different magnitude. The more interesting additional comparison is, of course, that having to do with the differing effects of the two supernatant-containing preparations, the nonspecific and specific, especially since the albumin concentration, although in each case higher than in the control run, was the same during either supernatant-containing run. To do this, we compared the ratio of the average extraction during antibody infusion with respect to its control during nonspecific (NS-1) and specific (K15/6) supernatant-containing infusions. This ratio was 0.55 for the NS-1 supernatant and 0.18 for the specific antibody. The change was again highly significant (Student's t test; the null hypothesis was rejected at the P<.01 level). This provides the needed comparison between the NS-1 supernatant-and specific antibodyinfused runs, both of which were carried out at the higher albumin concentration. The conclusion is that, in comparison with the effect of the nonspecific NS-1 supernatant, the specific K15/6 antibody resulted in a highly significant inhibition of cumulative tracer palmitate uptake. The data document unequivocally in a model-independent fashion that the specific antibody specifically decreased the single-passage cumulative free fatty acid uptake.
The analysis will now be carried forward to try to ascertain the site at which the effect is taking place. We already know that the antibody being used will inhibit the uptake of free fatty acid by isolated cardiac myocytes13 and that in these cells it has an effect at the level of the cardiac sarcolemmal free fatty acid transporter. In the present experiments, both runs were carried out within 15 In the present data set, inspection indicates that the proportion of tracer leaving the capillaries over the early parts of the curve (as assessed by the proportional deviation of the labeled palmitate curve from its reference-labeled albumin curve or by its mathematical complement, the "instantaneous extraction") is substantial under control conditions. In the K15/6 supernatant-containing experiments, those of greatest interest, there is a major change in comparison with the control run. The deviation from the albumin curves becomes quite small; the two curves almost correspond. After the NS-1 supernatant-containing infusion, the diminution in the labeled-palmitate deviation from the labeledalbumin curve was much less marked. Bassingthwaighte et a125 have suggested that, with previous knowledge of the endothelial cell volume from a tracer taken up by the endothelial cells in a definable fashion, it should be possible to characterize the permeability of the two surfaces of the endothelial cells for a substance traversing these cells and that it may be possible to do this for palmitate, especially if, in the modeling, one sets the permeation of palmitate tracer through the interendothelial cell junctions to zero. In the present instance, the experiments were not designed in such a fashion as to make this kind of analysis possible. There is also the additional complicating feature for palmitate that measurements of cytoplasmic fatty acid-binding protein in cardiac capillary endothelial cells indicate that concentration of this in these cells is very low,26 :0.1% of the level in cardiomyocytes, so that it is unlikely that the endothelial space for free fatty acids will be perceptible as a separate entity. Therefore, we fitted the two-barrier modeling previously used by Rose and Goresky,4 which does not treat the endothelial cell volume as a definable feature, to the experimental data. This demonstrated, especially for the data acquired during the K15/6 supernatant infusion, that the proportion of tracer that passed along the capillary without leaving was large, as one would have expected from the nature of the data, and also that the proportion of the tracer returning from Fig 3. Most of the labeled palmitate profile is, in each case, made up of tracer that passed along the capillary without leaving the vasculature, the throughput component, which is shaded. The tracer that escaped the vasculature to return later in time, the returning component, is indicated by the difference between the experimental data and the shaded throughput component. To indicate the magnitude of the returning component in a separable fashion, this has also been replotted as a clear component along the abscissa. It is generally small in magnitude and spread out in time.
The albumin curve, which serves as the vascular reference, is also illustrated. The effects of the specific antibody infusion are displayed in the left panels and those of the NS-1 supernatant infusion in the right panels; the effects of the two are substantially divergent.
The analysis also indicated that the relative space of distribution for tracer palmitate in the interstitium was expanded under the conditions used in the present protocol. The error in the measurement of the capillary permeability-surface area product was quite small. In contrast, under all of the experimental circumstances, because the proportion of the tracer perceived by the modeling as returning to the circulation was exceedingly small, the statistical uncertainty relating to the determination of events beyond the initial passage of tracer out of the capillary became large, even with this more simple approach.27 With the present set of experimental protocols, the inference of an expanded relative distribution space for palmitate outside the capillaries appears sensible. In the dog, for instance, the concentration of albumin in plasma under ordinary circumstances is -590 ,mol/L (which is equivalent to 4 g/100 mL), and that in the interstitial space is of the order of 0.33 of this. 4 In the present experiments, the levels of albumin used in the infusion ranged from 0.66 to 0.89 ,umol/L. Thus, although the concentration of albumin in the interstitial pool will initially be at normal levels, it will begin to decrease during the infusion, likely at a slow rate. The ratio of interstitial to plasma albumin will nevertheless be elevated substantially with respect to the normal situation. This will have the effect of correspondingly expanding the apparent interstitial space of distribution available to palmitate. The results observed are therefore of the sort expected. Estimates for the permeability-surface area product for labeled palmitate derived from the modeling are listed in the Table. Values obtained by analysis with an even simpler model, without return of tracer to the circulation, were in each instance slightly smaller. Since their addition to the data set provides no additional information, they have not been tabulated. It is appropriate first to examine the values for the permeabilitysurface area product for palmitate that were provided by the analysis. In the control situation, the permeability-surface area products for labeled palmitate were larger than those for labeled sucrose. During the NS-1 supernatant-containing experiments, it was of the same order as that for sucrose, and during the specific K15/6 antibody infusion, it was lower than that for sucrose. In the NS-1 myeloma supernatant-containing experiments, the average value for the labeled-palmitate permeability-surface area product was 0.0239 mL s-1 g 1 for the control runs, and during the infusion of supernatant, the average became 0.0134 mL* s-1 * g`1. The change was significant (paired t test; the null hypothesis was rejected at the P<.05 level). In the control runs for the specific-antibody experiments, the average value for the labeled-palmitate permeability-surface area product was 0.0270 mL * s'1 g-1; and during infusion of the specific K15/6 antibody, it became 0.0056 mL* s-1 . g`1. The change was highly significant (paired t test; the null hypothesis was rejected at the P<.01 level). The difference in permeability (control value minus that for the supernatant-containing run) was also examined. This difference was larger for the specific K15/6 antibody-containing experiments (onetailed t test; the null hypothesis was rejected at the P<.05 level).
There was, in the second runs of the NS-1 supernatant-containing experiments, a significant decrease in flow. With the resulting increase in transit time, this would have been expected to lead to an increase in the extraction of tracer palmitate in the NS-1 supernatantcontaining runs. Therefore, it was important to analyze the data further, to quantify them in a fashion in which flow effects are implicitly put aside in the analysis. The effect of flow is not only on transit time; the permeability-surface area product for transcapillary exchange also varies with flow.9 In the model analysis of the data, transit time and permeability-surface area product are separated. Since labeled sucrose and labeled palmitate are exchanged across the same sets of capillaries, with the present experimental design the ratio of the labeled palmitate permeability-surface area product to that for sucrose provides a flow-independent index of how capillary palmitate transfer has changed in the various protocols explored with the present experiments. The values of the ratio of the labeled-palmitate permeability-surface area product to that simultaneously determined for labeled sucrose are therefore also listed in the Table. In the nonspecific NS-1 supernatant-containing case, the average ratio value changed from a control value of 1.68 to 1.04 for the supernatant-containing runs (paired t test, P<.05), and in the specific K15/6 anti-body-containing series, it changed from a control value of 1.80 to 0.52 with the specific antibody-containing runs (paired t test, P<.01). The proportional decrease in the permeability-surface area product for palmitate in the control to the NS-1 supernatant-perfused case, which we expect primarily to reflect the effect of the higher albumin concentration, was 0.38. The change is comparable to the calculated proportional decrease in the unbound palmitate concentration, from control to supernatant-containing infusion, of 0.36. The observed decrease in the permeability-surface area product for palmitate with the NS-1 infusion thus appears to mirror the decrease in the concentration of unbound palmitate, secondary to the higher albumin concentration. A decrease of similar magnitude would have been expected with the specific antibody-containing infusion, as a result of its identical albumin concentration. The observed proportional decrease with the specific antibody-containing perfusion was 0.71, a much larger value.
The permeability-surface area product for sucrose was found to diminish significantly, from the control to supernatant-containing run, in the K15/6 specific antibody-containing experiments. Therefore, finally, to normalize out the effect of this change, the values for the ratio of test (ie, supernatant containing) to control and for the ratio of palmitate permeability-surface area product to that for sucrose were examined. The average ratio of the paired test-to-control (permeability surface area for palmitate to the permeability surface area for sucrose) ratios was 0.30 for the specific K15/6 series and 0.61 for the NS-1 series. Statistical analysis (Student's t test) indicated that, in comparison with the NS-1 series, the value obtained for this ratio of ratios with the K15/6 antibody was significantly smaller; the null hypothesis was rejected (P<.05). The comparison demonstrates a specific inhibition of the capillary uptake of palmitate during the K15/6 infusion in excess of that defined with the NS-1 infusion, which is associated with the higher albumin concentration that is common to both. The inhibition is independent of flow and capillary surface area changes.
The conclusion arising from the present study is thus that the specific antibody for the free fatty acid transporter inhibits the transfer of labeled palmitate across the capillary endothelium in the rat heart.
Discussion
Although fatty acids normally represent the most important energy source of the heart, the mechanisms by which they are taken up into the heart have been incompletely described. Because of the lipophilic character of fatty acids, it has long been assumed that they might diffuse directly through the phospholipid bilayer of plasma membranes before they undergo further intracellular metabolism.28 Fatty acids are ordinarily presented to the heart tightly bound to albumin within the circulation. Since only a minute fraction of circulating albumin is taken up into cells by endocytosis29 and the passage of albumin into the interstitium is slow,7 for the rapid transfer ordinarily underlying fatty acid uptake, fatty acids must dissociate from the albumin molecule before they permeate the capillary endothelium. This kind of separation of tightly bound materials from albumin has previously been demonstrated for materials entering the liver cells. 30, 31 There is, of course, an underlying movement of albumin across the capillary endothelium, which is much slower and which underlies the exchange of the plasma and interstitial albumin pools.4 At a morphological level, this slower process of albumin exchange appears to take place via transcytosis, and the transport of labeled-albumin fatty acid has been found to be more active by a factor of 2 to 3 across the murine lung capillary endothelium than the transport of the same tracers not complexed to fatty acids.32 On binding its first two fatty acids, bovine serum albumin changes its axial ratio from 4 to 2.2 (see Reference 33); the manner in which the fatty acid binding mediates the acceleration in albumin transfer is nevertheless not entirely clear.
The data presented in the present study are consistent with the concept that rapid free fatty acid transfer across the cardiac capillary endothelium is a mediated process involving the endothelial cells. The magnitude of the transfer process under ordinary circumstances,4 together with the limitations imposed by tight binding of fatty acids to albumin (which would lead to an expected proportional paracellular endothelial transfer rate for albumin-bound fatty acids a great deal smaller than that for sucrose), leads one to surmise that diffusion of palmitate via paracellular routes does not contribute appreciably to the transfer. The present data also enable one to infer that a passive process such as lateral diffusion of fatty acids within the lipid of the cell membranes of the endothelial cells is also unlikely to provide a major path, since this would not be expected to be modified by a specific antibody. Similar arguments have been made by Bassingthwaighte et al. 29 An endothelial cell transfer mechanism appears responsible for most of the process.
Such a mechanism has previously been postulated to account for the high cellular uptake rates of fatty acids with in vivo single-pass extractions of the order of 40%,4,29,34,35 but a direct demonstration of the presence of such a system at the level of the capillary endothelial cells has been lacking.
Direct evidence for the existence of such a carriermediated uptake process for free fatty acid in other cells has been derived from the identification of high-affinity binding sites for long-chain fatty acids on plasma membranes of hepatocytes, cardiomyocytes, and jejunal mucosal cells133637 and an evaluation of the transmembrane translocation process for fatty acids in these cell types, which has revealed kinetic criteria characteristic of a facilitated transport mechanism.10-'5 These include saturability of uptake and Km values of 70 to 90 nmol/L, indicating a high affinity for this transporter.
To identify the responsible membrane carrier protein with high affinity for fatty acids, detergent-solubilized plasma membranes of rat hepatocytes, cardiomyocytes, and mucosal cells were chromatographed in a single step over an oleate agarose affinity column by Stremmel et al.36 This resulted in the isolation of a single 40 40 This protein, with a molecular mass of 43 kD, a pl of 9.5 to 10, and an mRNA of 2.4 kb, appears to be functionally and structurally different from the membrane fatty acid-binding protein against which antibodies were raised for the present study.15 '38 A parallel approach to the characterization of free fatty acid transport in isolated adipocytes has also been developed. Abumrad Although in these previous studies the presence of the membrane fatty acid-carrier system was established in cardiomyocytes,13 the overall uptake system for fatty acids in the heart is more complex, involving, as indicated above, their translocation across the capillary endothelial cell layer and the subjacent interstitial space for presentation to the sarcolemmal surface of the cardiomyocytes. In addition to the albumin in the interstitial space, there is a high level of cytoplasmic fatty acid-binding protein in the heart muscle cells and a low level of this protein in cultured endothelial cells. 26 The present studies now demonstrate that, for the rapid and efficient uptake of fatty acids by the heart, the capillary endothelial cells are of primary importance. To A model analysis of the dilution curves was carried out to document both the site of this effect and its magnitude. Values for the capillary permeability-surface area product for palmitate were obtained simultaneously with those for labeled sucrose, an interstitial reference. Since labeled sucrose and palmitate permeation occur across the same set of capillaries, variations in flow, transit time, and capillary surface area in the experiments were implicitly put aside in the analysis by considering the ratio of capillary palmitate permeability-surface area product to that for sucrose in the test (ie, supernatant containing) to the control situation. The value for this ratio was 0.61 for the NS-1 myeloma supernatant-containing experiments, which reflected the albumin effect, and 0.30 for the specific K15/6 antibody. There was significant inhibition by the specific antibody, over and above the albumin effect. The inhibition is attributed to the binding of the antibody to a membrane fatty acid-binding protein that functions as a carrier protein for fatty acids in the capillary endothelial cells of the heart. The major degree of inhibition imposed, in terms of the effect on cumulative extraction, also makes it likely that this is the principal mechanism underlying the transfer of free fatty acids across the capillary endothelium. One can infer that this mechanism likely functions at both surfaces of the endothelial cell, and one can also surmise that in skeletal muscle, where fatty acids are also the principal fuel, and in fat tissue, where large bidirectional fluxes of fatty acid from blood to tissue are occurring, a similar or identical mechanism will be operating in the capillary endothelial cells.
The present study thus provides direct experimental evidence that the transfer process for free fatty acids localized to the capillary endothelial cells of the heart is found not to bind fatty acids and was not hemolytic, so mediated by a membrane fatty acid-binding protein.
The Role of Albumin in the Transfer Process
The present experiments were not directed at and do not elucidate the role of albumin in the transfer process for free fatty acids in the heart. Because of its large fatty acid-binding capacity, albumin has a potential variety of effects on the process. Experimental evidence regarding these has not yet entirely clarified what is occurring. The major point at issue has been the rate at which fatty acid unbinds from albumin. If, as has been postulated in the past, unbinding from albumin is slow with respect to the time of capillary transit,43 much of the albuminbound fatty acid would not be expected to be accessible to uptake unless some secondary mechanism at the endothelial surface promotes either the release of fatty acids from albumin or a catalyzed direct transfer of the albumin-bound form to the endothelial cells. On the other hand, if, as has been postulated more recently, the dissociation rate is not limiting,34'44'45 transfer will vary with unbound fatty acid concentrations, and the albumin-bound moeity will serve as an additional accessible accessory pool,16 so that, when rates of uptake are high, transfer will also change with total albumin concentration. The present data bring into focus the additional possibility that there may be another controlled variable in the system, the amount and activity of the free fatty acid transporter in the endothelial cells. The area clearly needs additional experimental exploration.
The picture that emerges is that free fatty acid in plasma, bound to albumin, is taken up by a capillary endothelial transport process, diffuses across the endothelial cells, passes across the albuminal membrane via a transporter in that surface, binds to albumin in the interstitium, and diffuses across that region, to be taken up by a transport process at the surface of the cardiomyocyte.
